0
Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

½É³úÇ÷°üÁúȯ À§Çè¿äÀÎÀ» °¡Áø Á߳⿩¼ºÀ» À§ÇÑ ÅëÇÕÀû »ýÈ°½À°ü°³¼± ÇÁ·Î±×·¥ÀÇ È¿°ú

Effects of a Comprehensive Lifestyle Improvement Program for Middle-aged Women with Cardio-cerebrovascular Disease-related Risk Factors

Áö¿ª»çȸ°£È£ÇÐȸÁö 2013³â 24±Ç 2È£ p.111 ~ 122
KMID : 0607720130240020111
¹Ú¹Ì°æ ( Park Mi-Kyoung ) - Á¦ÁÖ°ü±¤´ëÇб³ °£È£°ú

±èÁ¤Èñ ( Kim Jeong-Hee ) - Á¦ÁÖ´ëÇб³ °£È£´ëÇÐ

Abstract

Purpose: This study was conducted to evaluate effects of a comprehensive lifestyle improvement program for middle-aged women with cardio-cerebrovascular disease (CVD)-related risk factors. Methods: The research adopted a non-equivalent control group pretest-posttest design. The number of participants was 18 in the experimental group and 16 in the control group sampled among middle-aged women who had CVD-related risk factors residing in a community. The experimental group participated in a four-session comprehensive lifestyle promotion program, which consisted of lectures, demonstrations, small-group meetings and telephone-counseling. The effects of the program were evaluated by measuring knowledge, attitude, health behavior, and self-efficacy for CVD prevention. Results: The experimental group showed a significant increase in self-efficacy for CVD prevention compared to the control group. There was no significant increase in knowledge, attitude, and health behavior. Conclusion: The results suggest that the comprehensive lifestyle improvement program was effective in improving self-efficacy for CVD prevention. There is a need to develop more effective lifestyle improvement programs designed to improve knowledge, attitude, and health behavior for CVD prevention. In further research, a follow-up evaluation is also needed to investigate any delayed effects on targeted variables among which no significant differences emerged immediately after the completion of the program.
KeyWords
½É³úÇ÷°üÁúȯ, Áß³â, ¿©¼º, »ýÈ°½À°ü
Cardiovascular diseases, Cerebrovascular disorders, Middle-aged, Women, Lifestyle
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
 
µîÀçÀú³Î Á¤º¸
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed